During the past decade, Tata Medical Center conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.6% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 1 clinical trials were completed. i.e. 5.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tata Medical Center" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Tata Medical Center" with 4 trials sponsored, "Johnson & Johnson Private Limited" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Karyopharm Therapeutics Inc" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tata Medical Center" #1 collaborator was "Indian Society of Critical Care Medicine" with 1 trials as a collaborator, "Kortuc, Inc." with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "Orion Corporation, Orion Pharma" with 1 trials as a collaborator and "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Tata Medical Center" are "Multiple Myeloma" (4 trials), "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Lymphoma, Mantle-Cell" (3 trials) and "Leukemia, Lymphocytic, Chronic, B-Cell" (2 trials). Many other conditions were trialed in "Tata Medical Center" in a lesser frequency.

Most popular intervention types in "Tata Medical Center" are "Drug" (21 trials), "Other" (4 trials), "Radiation" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amivantamab" (3 trials), "Bortezomib" (3 trials), "Dexamethasone" (3 trials), "Lenalidomide" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tata Medical Center" are 23 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Tata Medical Center". undefined are not yet recruiting, 13 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Tata Medical Center, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tata Medical Center, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 4 trials that are defined as “Not Applicable".

Tata Medical Center has several departments that took part in Clinical trials: "TATA Medical Centre; Medical Oncology" - 4 trials, "Tata Medical Center; Department of Medical Oncology" - 2 trials